Annexin A1: potential for glucocorticoid sparing in RA. (Q38130080)

29 August 2017

title

Annexin A1: potential for glucocorticoid sparing in RA. (English)

1 reference

29 August 2017

Yuan H Yang

1

1 reference

29 August 2017

Eric Morand

series ordinal

2

1 reference

29 August 2017

Michelle Leech

series ordinal

3

1 reference

29 August 2017

language of work or name

English

0 references

publication date

20 August 2013

1 reference

Nature Reviews Rheumatology

29 August 2017

published in

1 reference

29 August 2017

volume

9

1 reference

29 August 2017

issue

10

1 reference

29 August 2017

page(s)

595-603

1 reference

The genetics revolution and the assault on rheumatoid arthritis

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

The multiple facets of glucocorticoid action in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Annexin A1 and glucocorticoids as effectors of the resolution of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Critical protective role for annexin 1 gene expression in the endotoxemic murine microcirculation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Annexin 1 induced by anti-inflammatory drugs binds to NF-kappaB and inhibits its activation: anticancer effects in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Deficiency of annexin A1 in CD4 T cells exacerbates T cell-dependent inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Glucocorticoids in the treatment of rheumatic diseases: an update on the mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Glucocorticoid-induced osteonecrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

The impact of endogenous annexin A1 on glucocorticoid control of inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Modulation of inflammation and response to dexamethasone by Annexin 1 in antigen-induced arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Annexins and membrane dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Exploiting the Annexin A1 pathway for the development of novel anti-inflammatory therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Annexin 1: the new face of an old molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Attenuation of glucocorticoid functions in an Anx-A1-/- cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Role of lipocortin I in the glucocorticoid induction of the terminal differentiation of a human squamous carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Annexins: from structure to function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Annexin A1 regulates intestinal mucosal injury, inflammation, and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Evidence for an anti-inflammatory loop centered on polymorphonuclear leukocyte formyl peptide receptor 2/lipoxin A4 receptor and operative in the inflamed microvasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Anti-inflammatory lipocortin 1 production by peripheral blood leucocytes in response to hydrocortisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Detection of intracellular lipocortin 1 in human leukocyte subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Measurement of lipocortin 1 levels in murine peripheral blood leukocytes by flow cytometry: modulation by glucocorticoids and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Comparative analysis of Annexin A1-formyl peptide receptor 2/ALX expression in human leukocyte subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Modulation of experimental autoimmune encephalomyelitis by endogenous annexin A1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Annexin-1 modulates T-cell activation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Impaired T cell activation and increased Th2 lineage commitment in Annexin-1-deficient T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

An annexin 1 (ANXA1)-derived peptide inhibits prototype antigen-driven human T cell Th1 and Th2 responses in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Annexin‐1‐deficient mice exhibit spontaneous airway hyperresponsiveness and exacerbated allergen‐specific antibody responses in a mouse model of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Evaluation of therapeutic targets in animal models of arthritis: how does it relate to rheumatoid arthritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Lessons from animal models of arthritis over the past decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Glucocorticoid therapy of antigen-induced arthritis depends on the dimerized glucocorticoid receptor in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Glucocorticoid treatment inhibits annexin-1 expression in rheumatoid arthritis CD4 T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Differential distribution of annexins-I, -II, -IV, and -VI in synovium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Regulation of annexin I in rheumatoid synovial cells by glucocorticoids and interleukin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Annexin-1 mediates TNF-alpha-stimulated matrix metalloproteinase secretion from rheumatoid arthritis synovial fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Annexin A1 and the regulation of innate and adaptive immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Regulation of lung fibroblast activation by annexin A1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Annexin A1 interaction with the FPR2/ALX receptor: identification of distinct domains and downstream associated signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Airway activation of formyl peptide receptors inhibits Th1 and Th17 cell responses via inhibition of mediator release from immune and inflammatory cells and maturation of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

The pyrazolone originally reported to be a formyl peptide receptor (FPR) 2/ALX-selective agonist is instead an FPR1 and FPR2/ALX dual agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Identification of novel small-molecule agonists for human formyl peptide receptors and pharmacophore models of their recognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Gastrin-releasing peptide/neuromedin B receptor antagonists PD176252, PD168368, and related analogs are potent agonists of human formyl-peptide receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Spatial and temporal profiles for anti-inflammatory gene expression in leukocytes during a resolving model of peritonitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Activation of the annexin 1 counter-regulatory circuit affords protection in the mouse brain microcirculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Reperfusion-induced myocardial dysfunction is prevented by endogenous annexin-A1 and its N-terminal-derived peptide Ac-ANX-A1(2-26).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Identification of an essential endogenous regulator of blood-brain barrier integrity, and its pathological and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Anti-inflammatory effects of Tat-Annexin protein on ovalbumin-induced airway inflammation in a mouse model of asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Annexin A1 modulates natural and glucocorticoid-induced resolution of inflammation by enhancing neutrophil apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Effect of annexin-A1 peptide treatment during lung inflammation induced by lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Results of a two-year followup study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Annexin-1 regulates macrophage IL-6 and TNF via glucocorticoid-induced leucine zipper

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Aberrant inflammation and resistance to glucocorticoids in annexin 1-/- mouse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

A novel calcium-dependent proapoptotic effect of annexin 1 on human neutrophils.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Annexin 1 mediates the rapid anti-inflammatory effects of neutrophil-derived microparticles

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Mobilizing lipocortin 1 in adherent human leukocytes downregulates their transmigration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Cleavage of annexin A1 by ADAM10 during secondary necrosis generates a monocytic "find-me" signal

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Lipocortin-1 (annexin-1) suppresses activation of autoimmune T cell lines in the Lewis rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Inhibitory effect of annexin I on synovial inflammation in rat adjuvant arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Antiinflammatory effect of lipocortin 1 in experimental arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Impaired glucocorticoid induction of mononuclear leukocyte lipocortin-1 in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Specific binding of lipocortin-1 (annexin I) to monocytes and neutrophils is decreased in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Annexin I surface binding sites and their regulation on human fibroblast-like synoviocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2013.126

Modulation of IL-1-induced neutrophil migration by dexamethasone and lipocortin 1

31 March 2020

1 reference

12 December 2020

N-formylpeptides induce two distinct concentration optima for mouse neutrophil chemotaxis by differential interaction with two N-formylpeptide receptor (FPR) subtypes. Molecular characterization of FPR2, a second mouse neutrophil FPR

1 reference

12 December 2020

Role of lipomodulin, a phospholipase inhibitory protein, in immunoregulation by thymocytes

1 reference

12 December 2020

Targeting the side effects of steroid therapy in autoimmune diseases: the role of GILZ.

1 reference

12 December 2020

Lipocortin-1 fragments inhibit neutrophil accumulation and neutrophil-dependent edema in the mouse. A qualitative comparison with an anti-CD11b monoclonal antibody.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRRHEUM.2013.126

1 reference

Dimensions Publication ID

29 August 2017

1001104880

0 references

1 reference